180 related articles for article (PubMed ID: 21972124)
21. Development and validation of the self-administered Fibromyalgia Assessment Status: a disease-specific composite measure for evaluating treatment effect.
Salaffi F; Sarzi-Puttini P; Girolimetti R; Gasparini S; Atzeni F; Grassi W
Arthritis Res Ther; 2009; 11(4):R125. PubMed ID: 19686606
[TBL] [Abstract][Full Text] [Related]
22. The comparative burden of mild, moderate and severe fibromyalgia: results from a cross-sectional survey in the United States.
Schaefer C; Chandran A; Hufstader M; Baik R; McNett M; Goldenberg D; Gerwin R; Zlateva G
Health Qual Life Outcomes; 2011 Aug; 9():71. PubMed ID: 21859448
[TBL] [Abstract][Full Text] [Related]
23. Usefulness of tenderness to characterise fibromyalgia severity in women.
Aparicio VA; Carbonell-Baeza A; Ortega FB; Estevez F; Ruiz JR; Delgado-Fernández M
Clin Exp Rheumatol; 2011; 29(6 Suppl 69):S28-33. PubMed ID: 21813058
[TBL] [Abstract][Full Text] [Related]
24. Validation of a German version of the Fibromyalgia Impact Questionnaire (FIQ-G).
Offenbaecher M; Waltz M; Schoeps P
J Rheumatol; 2000 Aug; 27(8):1984-8. PubMed ID: 10955342
[TBL] [Abstract][Full Text] [Related]
25. Psychometric properties of the Fibromyalgia Assessment Status (FAS) index: a national web-based study of fibromyalgia.
Iannuccelli C; Sarzi-Puttini P; Atzeni F; Cazzola M; di Franco M; Guzzo MP; Bazzichi L; Cassisi GA; Marsico A; Stisi S; Salaffi F
Clin Exp Rheumatol; 2011; 29(6 Suppl 69):S49-54. PubMed ID: 22011656
[TBL] [Abstract][Full Text] [Related]
26. Attention-deficit hyperactivity disorder symptoms and quality of life in female patients with fibromyalgia.
Türkoğlu G
Turk J Med Sci; 2021 Aug; 51(4):1747-1755. PubMed ID: 33512815
[TBL] [Abstract][Full Text] [Related]
27. Evaluating Disease Severity in Chronic Pain Patients with and without Fibromyalgia: A Comparison of the Symptom Impact Questionnaire and the Polysymptomatic Distress Scale.
Friend R; Bennett RM
J Rheumatol; 2015 Dec; 42(12):2404-11. PubMed ID: 26523027
[TBL] [Abstract][Full Text] [Related]
28. Health-related quality of life in fibromyalgia patients: a comparison with rheumatoid arthritis patients and the general population using the SF-36 health survey.
Salaffi F; Sarzi-Puttini P; Girolimetti R; Atzeni F; Gasparini S; Grassi W
Clin Exp Rheumatol; 2009; 27(5 Suppl 56):S67-74. PubMed ID: 20074443
[TBL] [Abstract][Full Text] [Related]
29. A double-blind, multicenter trial comparing duloxetine with placebo in the treatment of fibromyalgia patients with or without major depressive disorder.
Arnold LM; Lu Y; Crofford LJ; Wohlreich M; Detke MJ; Iyengar S; Goldstein DJ
Arthritis Rheum; 2004 Sep; 50(9):2974-84. PubMed ID: 15457467
[TBL] [Abstract][Full Text] [Related]
30. Health-related quality of life in women with fibromyalgia: clinical and psychological factors associated.
Campos RP; Vázquez Rodríguez MI
Clin Rheumatol; 2012 Feb; 31(2):347-55. PubMed ID: 21979445
[TBL] [Abstract][Full Text] [Related]
31. Effect of a 24-week physical training programme (in water and on land) on pain, functional capacity, body composition and quality of life in women with fibromyalgia.
Latorre PÁ; Santos MA; Heredia-Jiménez JM; Delgado-Fernández M; Soto VM; Mañas A; Carbonell-Baeza A
Clin Exp Rheumatol; 2013; 31(6 Suppl 79):S72-80. PubMed ID: 24373364
[TBL] [Abstract][Full Text] [Related]
32. Sex-Related Differences in Symptoms and Psychosocial Outcomes in Patients With Fibromyalgia: A Prospective Questionnaire Study.
Jiang L; D'Souza RS; Oh T; Vincent A; Mohabbat AB; Ashmore Z; Mauck WD; Ge L; Whipple MO; McAllister SJ; Wang Z; Qu W
Mayo Clin Proc Innov Qual Outcomes; 2020 Dec; 4(6):767-774. PubMed ID: 33367213
[TBL] [Abstract][Full Text] [Related]
33. Evaluation of patient-rated stiffness associated with fibromyalgia: a post-hoc analysis of 4 pooled, randomized clinical trials of duloxetine.
Bennett R; Russell IJ; Choy E; Spaeth M; Mease P; Kajdasz D; Walker D; Wang F; Chappell A
Clin Ther; 2012 Apr; 34(4):824-37. PubMed ID: 22421576
[TBL] [Abstract][Full Text] [Related]
34. Fibromyalgia Symptom Severity and Psychosocial Outcomes in Fibromyalgia Patients with Hypovitaminosis D: A Prospective Questionnaire Study.
D'Souza RS; Lin G; Oh T; Vincent A; Orhurhu V; Jiang L; Mauck WD; Qu W
Pain Med; 2020 Dec; 21(12):3470-3478. PubMed ID: 32022867
[TBL] [Abstract][Full Text] [Related]
35. Tobacco Use in Fibromyalgia Is Associated With Cognitive Dysfunction: A Prospective Questionnaire Study.
Ge L; D'Souza RS; Oh T; Vincent A; Mohabbat AB; Eldrige J; Jiang L; Whipple MO; McAllister SJ; Wang Z; Qu W; Mauck WD
Mayo Clin Proc Innov Qual Outcomes; 2019 Mar; 3(1):78-85. PubMed ID: 30899911
[TBL] [Abstract][Full Text] [Related]
36. An open-label study of quetiapine in the treatment of fibromyalgia.
Hidalgo J; Rico-Villademoros F; Calandre EP
Prog Neuropsychopharmacol Biol Psychiatry; 2007 Jan; 31(1):71-7. PubMed ID: 16889882
[TBL] [Abstract][Full Text] [Related]
37. The relationship between body mass index and pain, disease activity, depression and anxiety in women with fibromyalgia.
Koçyiğit BF; Okyay RA
PeerJ; 2018; 6():e4917. PubMed ID: 29868295
[TBL] [Abstract][Full Text] [Related]
38. The impact of mood, anxiety, and sleep disorders on fibromyalgia.
Consoli G; Marazziti D; Ciapparelli A; Bazzichi L; Massimetti G; Giacomelli C; Rossi A; Bombardieri S; Dell'Osso L
Compr Psychiatry; 2012 Oct; 53(7):962-7. PubMed ID: 22534032
[TBL] [Abstract][Full Text] [Related]
39. Validation of an Italian version of the Fibromyalgia Impact Questionnaire (FIQ-I).
Sarzi-Puttini P; Atzeni F; Fiorini T; Panni B; Randisi G; Turiel M; Carrabba M
Clin Exp Rheumatol; 2003; 21(4):459-64. PubMed ID: 12942697
[TBL] [Abstract][Full Text] [Related]
40. A randomized trial of tai chi for fibromyalgia.
Wang C; Schmid CH; Rones R; Kalish R; Yinh J; Goldenberg DL; Lee Y; McAlindon T
N Engl J Med; 2010 Aug; 363(8):743-54. PubMed ID: 20818876
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
